Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

EuroIntervention. 2020 Jan 17;15(13):1125-1129. doi: 10.4244/EIJY19M10_01.

Authors

Mariusz Tomaniak¹, Robert F Storey, Patrick W Serruys

Affiliation

¹ Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands.

PMID: 31595880
DOI: 10.4244/EIJY19M10_01

No abstract available

MeSH terms

Drug Therapy, Combination
Humans
Percutaneous Coronary Intervention / adverse effects
Percutaneous Coronary Intervention / methods
Platelet Aggregation Inhibitors / administration & dosage*
Postoperative Complications*
Ticlopidine
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Ticlopidine